Beta Drugs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Beta Drugs Limited has filed a disclosure under Regulation 31(4) of SEBI SAST Regulations, 2011, submitted by promoters Rahul Batra, Mr Varun Batra, Mrs Neeraj Batra, Mrs Aditi Batra, and Mrs Heena Batra. The key finding of this disclosure is that there is no encumbrance on the shares held by the promoters as of 31st March 2026. This is a routine regulatory filing where promoters confirm the status of their share pledges to the stock exchange and the company. The disclosure includes details about promoter holdings and encumbrance status, but no encumbrance events (creation, release, or invocation) have occurred during the reporting period.